TP53 and spleen angiosarcoma: Furthermore, in splenic hemangiosarcoma, NRAS mutations are mutually exclusive with TP53 mutations (p < 0.01) and PIK3CA mutations (not significant, likely due to small sample size) (Fig. 5b), consistent with a previous study3.